SAP1 (PTPRH) (NM_002842) Human Tagged ORF Clone Lentiviral Particle

CAT#: RC215011L1V

Lenti ORF particles, PTPRH (Myc-DDK-tagged)-Human protein tyrosine phosphatase, receptor type, H (PTPRH), transcript variant 1, 200ul, >10^7 TU/mL

Specifications

Product Data

• Type: Human Tagged ORF Clone Lentiviral Particle
• Tag: Myc-DDK
• Symbol: PTPRH
• Synonyms: R-PTP-H; SAP1
• Vector: pLenti-C-Myc-DDK
• ACCN: NM_002842
• ORF Size: 3345 bp
• Sequence Data:
  ORF Nucleotide Sequence

  The ORF insert of this clone is exactly the same as(RC215011).
• OTI Disclaimer: The molecular sequence of this clone aligns with the gene accession number as a point of reference only. However, individual transcript sequences of the same gene can differ through naturally occurring variations (e.g. polymorphisms), each with its own valid existence. This clone is substantially in agreement with the reference, but a complete review of all prevailing variants is recommended prior to use. More info
• OTI Annotation: This clone was engineered to express the complete ORF with an expression tag. Expression varies depending on the nature of the gene.

Reference Data

• RefSeq: NM_002842.2, NP_002833.2
• RefSeq Size: 3895 bp
• RefSeq ORF: 3348 bp
• Locus ID: 5794
• Cytogenetics: 19q13.42
• Protein Families: Druggable Genome, Transmembrane
• MW: 122.2 kDa
• Gene Summary: 'The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and a single intracytoplasmic catalytic domain, and thus represents a receptor-type PTP. The extracellular region contains eight fibronectin type III-like repeats and multiple N-glycosylation sites. The gene was shown to be expressed primarily in brain and liver, and at a lower level in heart and stomach. It was also found to be expressed in several cancer cell lines, but not in the corresponding normal tissues. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2009]'